Evidence-based Clinical Care: Source-Based Antibiotic Power Plans for Sepsis
Sepsis, severe sepsis and septic shock are significant healthcare concerns for the U.S. population because of their high prevalence, morbidity, mortality and medical costs. Mortality from sepsis increases 8% for every hour that antibiotic treatment is delayed. Sepsis is a leading cause of death in U.S. hospitals. This course provides a review of the source-based antibiotic power plans for sepsis utilized at Baptist Health South Florida.
Note to Physicians: Be sure to bookmark this course to access all protocols, pathways, policies and procedures at your convenience via your CME Portal account. All power plans are available in Cerner. All EBCC deliverables will be available on the EBCC website.
Target Audience
Emergency Department Practitioners, Hospitalists, Intensivists, Infectious Disease Specialists, Advanced Practice Registered Nurses, Physician Assistants, Pharmacists, Pharmacy Technicians, Laboratory Technologists and Nurses.
Learning Objectives
- Identify key considerations for empiric antibiotic selection in patients with sepsis.
- Discuss guideline recommendations for antimicrobial therapy in the setting of sepsis or septic shock.
Timothy P. Gauthier, Pharm.D., BCPS, BCIDP
Director, ID PGY2 Pharmacy Residency Program
Manager, Antimicrobial Stewardship Clinical Program
Baptist Health South Florida
Miami, Florida
Richard Levine, M.D.
Infectious Disease Specialist
Baptist Hospital, Doctors Hospital and South Miami Hospital
Chairman, Antimicrobial Stewardship Committee, Doctors Hospital
Baptist Health South Florida
Miami, Florida
Lourdes R. Menendez, Pharm.D., BCPS
PGY2 Infectious Diseases Pharmacy Resident
Baptist Health South Florida
Miami, Florida
Timothy P. Gauthier, Pharm. D., BCPS, BCIDP, faculty for this educational activity, is a consultant with Pattern Biosciences (formerly Klaris Diagnostics), DoseMeRx by Tabula Rasa, Pfizer and MeMed. All of the relevant financial relationships listed for this individual have been mitigated.
Richard L. Levine, M.D., faculty for this educational activity, has no relevant financial relationships to disclose with ineligible companies*.
Lourdes R. Menendez, Pharm. D., BCPS, content contributor for this educational activity, has no relevant financial relationships to disclose with ineligible companies*.
Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose with ineligible companies*.
*Ineligible companies – Companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 General certificate of attendance
- 1.00 Florida Board of Laboratory Personnel
- 1.00 Nurse Practitioners
- 1.00 Florida Board of Nursing
- 1.00 Florida Board of Pharmacy
Required Hardware/Software
PC/Mac UsersThis site is supported on the most recent stable releases of the following browsers:
| |||||||
Mobile UsersThis site is supported on the following mobile devices:
| |||||||
Technical SupportIf you are experiencing technical difficulties or have received an error message, please send an email to CME@baptisthealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours. |